Pankreatin Klinge (Pancreatin)

Pancreatin is used in pancreatic enzyme replacement therapy to address digestive deficiencies associated with exocrine pancreatic insufficiency.

• Cystic fibrosis‑related pancreatic insufficiency: improves digestion of fats, proteins and carbohydrates, helping to maintain nutritional status.
• Chronic pancreatitis with exocrine insufficiency: reduces steatorrhea and abdominal discomfort by supplementing deficient digestive enzymes.
• Post‑surgical pancreatic insufficiency (e.g., after pancreatic resection): supports nutrient absorption and mitigates malabsorption symptoms.
• Pancreatic cancer patients receiving chemotherapy: assists in maintaining caloric intake by enhancing digestion of macronutrients.
• Pancreatic duct obstruction causing enzyme deficiency: alleviates malabsorption and reduces fatty stools.

• Pancreatin contains a mixture of digestive enzymes—amylase, lipase and protease—that hydrolyze carbohydrates, fats and proteins respectively. After oral administration, the enzymes are released in the duodenum where they complement the deficient pancreatic secretions, facilitating breakdown of nutrients and improving their absorption across the intestinal mucosa. The formulation is protected by enteric coating to resist gastric acid, ensuring maximal activity in the alkaline environment of the small intestine.

Pancreatin may cause a range of adverse reactions, most of which are mild and related to gastrointestinal tolerance.

Common Side Effects

• Abdominal discomfort or cramping: mild pain in the stomach area.
• Flatulence or bloating: increased gas production.
• Diarrhea or loose stools: frequent watery bowel movements.
• Nausea or mild vomiting: sensation of queasiness.
• Constipation: difficulty passing stool.

Serious or Rare Side Effects

• Allergic reactions such as rash, urticaria or anaphylaxis: signs of hypersensitivity.
• Severe abdominal pain indicating possible pancreatitis exacerbation.
• Intestinal obstruction or ileus: blockage of the bowel requiring medical attention.

When prescribing pancreatin, several precautionary measures should be observed to ensure safety and efficacy.

• Assess pancreatic insufficiency: confirm diagnosis before initiating therapy.
• Monitor for allergic reactions: discontinue if rash, swelling or anaphylaxis occurs.
• Adjust dose in renal or hepatic impairment: use the lowest effective dose and monitor clinical response.
• Avoid in patients with known hypersensitivity to porcine‑derived enzymes.
• Use cautiously in gastrointestinal disorders such as ulcerative colitis or Crohn’s disease.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Pancreatin can interact with certain medications, affecting its efficacy or increasing the risk of adverse effects.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: may bind enzymes and reduce their activity.
• High‑dose proton pump inhibitors: can decrease gastric acidity needed for enzyme activation.
• Orlistat: binds pancreatic lipase, diminishing fat digestion.

Moderate Interactions (Monitor Closely)

• Warfarin: altered vitamin K absorption may affect anticoagulation control.
• Digoxin: electrolyte changes from malabsorption can influence serum levels.
• Antibiotics such as tetracycline: may affect gut flora and enzyme function.